secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001213900-24-002248
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics files patent for weight loss therapeutic and side effect mitigation
--------------------------------------------------------------------------------

- Filed a patent application with USPTO on January 8, 2024 for a therapeutic targeting obesity and side effects of weight loss drugs.
- Application aims to mitigate adverse effects associated with GLP-1 agonists, anticonvulsants, opioid antagonists, and NRIs.
- No details disclosed on the specific compound, mechanism, or development stage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024002248/0001213900-24-002248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024002248/ea191413-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-002248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer